CVE-2022-26235

Exploitation

Not assessed. CISA has not published an exploitation assessment for this record, and it is not in the KEV catalog. That is an absence of assessment, not a finding of no risk.

SSVC decision

Not assessed by CISA

EPSS probability

0.19% probability of exploitation activity in the next 30 days.

EPSS percentile

Ranks above 8.5% of scored records. A rank, not a probability.

NVD base score

7.8 (CVSS v3.x), scored by the NVD independently of the CNA.

NVD CVSS vector

CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H

NVD analysis status

Modified. NVD last modified this record on 2026-06-17.

Red Hat severity

No Red Hat rating. Red Hat rates the CVEs that affect its products.

Exploit-prediction scores from FIRST. Independent scoring and analysis status from the NVD. Vendor severity from Red Hat. Exploitation assessment and catalog membership from CISA.

Published

2022-10-06 00:00Z3 YR AGO

Last updated

2024-08-03 04:56Z2 YR AGO

Reserved

2022-02-28

Assigning CNA

mitre

Record state

PUBLISHED

Severity

Not rated by the issuing CNA

CNA CVSS vector

Not published by the issuing CNA

Weaknesses

• CWE-276Incorrect Default PermissionsBase

Data version

5.1

Document digest

4da4a29fdbdd2c6d9387aad4fc0c961b50783f161e316389b40c2ea615853388

• www.beckmancoulter.comhttps://www.beckmancoulter.com/products/clinical-information-management-tools/remisol-advance
• pastebin.comhttps://pastebin.com/amgw9pE7